denkapparat Operations’s Ultragenyx Pharmaceutical RARE Stock Holding History

denkapparat Operations’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Buy	+6,892	New	+$171K	0.08%	355
2025 Q4	–	Sell	-6,892	Closed	-$207K	–	308
2025 Q3	$207K	Hold	6,892	–	–	0.13%	264
2025 Q2	$251K	Hold	6,892	–	–	0.2%	205
2025 Q1	$250K	Buy	6,892 +1,980	+40%	+$82.4K	0.26%	175
2024 Q4	$207K	Buy	+4,912	New	+$244K	0.31%	154

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

denkapparat Operations's RARE Position: Q2 2026 in Review

denkapparat Operations opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 6,892 shares worth $230K. The stake represents 0.08% of the portfolio and ranks #355 among its holdings. This is a return to the name: denkapparat Operations previously reported a position in RARE as recently as Q3 2025.

denkapparat Operations first reported a position in RARE in Q4 2024 and has held it in 5 quarters since. The position peaked at $251K in Q2 2025. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

denkapparat Operations held 6,892 shares of Ultragenyx Pharmaceutical worth $230K as of Q2 2026.
Ultragenyx Pharmaceutical was a new denkapparat Operations position in Q2 2026.
Ultragenyx Pharmaceutical made up 0.08% of denkapparat Operations's portfolio in Q2 2026, its #355 holding.
denkapparat Operations first reported a position in Ultragenyx Pharmaceutical in Q4 2024 and has held it in 5 quarters since.
denkapparat Operations's Ultragenyx Pharmaceutical position peaked at $251K in Q2 2025.
311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on denkapparat Operations's 13F filing for Q2 2026, filed 6 Aug 2026.